Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Consulting agrmnt
Director departure
Appointed director

ORAMED PHARMACEUTICALS INC. (ORMP) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/31/2023 4 KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 120,000 shares @ $0
05/31/2023 4 Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 53,500 shares @ $0
05/31/2023 4 Derovan Netanel (Chief Legal Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 20,500 shares @ $0
05/31/2023 4 Hexter Joshua (COO & CBO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 27,000 shares @ $0
05/31/2023 4 Silberman David (CFO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 24,500 shares @ $0
05/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2023 4 Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Bought 5,009 shares @ $2.22, valued at $11.1k
Bought 3,800 shares @ $2.21, valued at $8.4k
03/16/2023 4 KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Bought 26,000 shares @ $2.039, valued at $53k
03/15/2023 4 KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Bought 100,000 shares @ $2.01, valued at $201k
03/15/2023 4 Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Sold 100,000 shares @ $2.01, valued at $201k
03/15/2023 4 Rozov Yadin (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Bought 20,000 shares @ $1.956, valued at $39.1k
Bought 50,000 shares @ $2.049, valued at $102.5k
01/04/2023 4 Rabinowitz Michael (Chief Commercial Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Sold 1,425 shares @ $13.0132, valued at $18.5k
Sold 11,900 shares @ $12.4917, valued at $148.7k
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2022 4 Sank Leonard (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Paid exercise price by delivering 9,304 shares @ $8.77, valued at $81.6k
Exercised 20,000 options @ $4.08, valued at $81.6k
08/01/2022 4 Rozov Yadin (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 12,000 shares @ $0
08/01/2022 4 Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 12,000 shares @ $0
08/01/2022 4 Derovan Netanel (Chief Legal Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 30,000 shares @ $0
08/01/2022 4 Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 34,000 shares @ $0
Granted 84,000 shares @ $0
08/01/2022 4 KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 34,000 shares @ $0
Granted 126,000 shares @ $0
Paid exercise price by delivering 12,631 shares @ $8.36, valued at $105.6k
08/01/2022 4 Hexter Joshua (COO & CBO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 42,000 shares @ $0
08/01/2022 4 Sank Leonard (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 12,000 shares @ $0
08/01/2022 4 Silberman David (CFO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 39,000 shares @ $0
08/01/2022 4 Rabinowitz Michael (Chief Commercial Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 30,000 shares @ $0
05/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2022 4 RAKIN KEVIN (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Sold 10,000 shares @ $9.4096, valued at $94.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy